News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
213 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37191)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53928)
2023 (42568)
2024 (38486)
2025 (17535)
Month
January (2488)
February (2603)
March (3229)
April (2950)
May (3962)
June (3500)
July (2854)
August (3142)
September (3205)
October (3540)
November (3386)
December (2332)
Day
1 (247)
2 (234)
3 (123)
4 (6)
5 (2)
6 (157)
7 (294)
8 (215)
9 (227)
10 (147)
11 (6)
12 (2)
13 (213)
14 (201)
15 (161)
16 (149)
17 (68)
19 (2)
20 (132)
21 (113)
22 (70)
23 (4)
24 (6)
26 (9)
27 (154)
28 (186)
29 (127)
30 (131)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
19
20
21
22
23
24
26
27
28
29
30
Business
Novo Nordisk Lays Off 185 Employees, Hiring 70 in Commercial Reorg
After falling short of analysts’ expectations in its latest quarter, Novo Nordisk is restructuring its commercial operations as it looks to fend off challenges to its products.
November 13, 2017
·
2 min read
·
Alex Keown
Drug Development
Argos Surges on Positive Phase III Kidney Cancer Data
Investors in beleaguered Argos are smiling this morning after the company announced some positive interim data for its Phase III kidney cancer drug, Rocapuldencel-T - a trial that some said should have been scrapped months ago.
November 13, 2017
·
2 min read
·
Alex Keown
Deals
Week in Review: China’s Creat to Restructure $1.5B Biotest Takeover
Creat Group will attempt to restructure its $1.5M offer to acquire Biotest after U.S. regulators nixed the deal.
November 13, 2017
·
1 min read
Job Trends
Real Estate Developers Eye Boston’s South End for Life Science Campus
The new space is located just a few miles from Kendall Square that has become the hub of the Boston biotech industry.
November 13, 2017
·
3 min read
·
Alex Keown
BioForest
Top 3 Best Biotechs of 2018
Noting that biotech stocks have been in “hypergrowth” mode over more than six years, George Budwell, writing for The Motley Fool, looks at three biotech stocks that he would recommend to investors.
November 13, 2017
·
2 min read
·
Mark Terry
Job Trends
Pfizer to Hire Up to 400 in Michigan for 2018
Pfizer is planning to hire 200 new staffers and another 200 replacement workers in Michigan.
November 13, 2017
·
3 min read
·
Mark Terry
BioMidwest
Medtronic’s Insulin Pump Dominance Boosted by Johnson & Johnson’s Exit
Good news seems to keep coming for medtech company Medtronic.
November 13, 2017
·
2 min read
·
Alex Keown
Career Advice
Heptares Founder Shares Her Best Life Sciences Career Advice
Fiona Marshall founded Heptares Therapeutics, which is now one of the leading biotech companies in the UK.
November 13, 2017
·
3 min read
·
Mark Terry
Drug Development
Novartis Showcases 4 Potential Blockbusters in Its Late-Stage Pipeline
Novartis is not resting on the laurels of having the first-ever-approval for a CAR-T cancer drug, Kymriah.
November 13, 2017
·
3 min read
·
Alex Keown
Biotech Bay
5 Reasons Why Top Scientists Dump Kendall Square for Silicon Valley
A look at the reasons why top life science talent from Boston’s Kendall Square biotech hub are moving to the San Francisco Bay Area.
November 13, 2017
·
6 min read
·
Mark Terry
1 of 22
Next